HOME - Companies - Products
 
 
16 February 2019

Bluephase G4: Ivoclar Vivadent has developed the first ever intelligent Bluephase

Stylish, reliable and clever: that’s Bluephase G4 – the first Bluephase curing light featuring an automated assistance system. For even better results.


Sound materials and reliable equipment are indispensable for achieving successful direct and indirect restorations. Here is something that many are not aware of, though: the precision with which the light-curing process is performed has also a substantial effect on the durability of composite restorations. This is where the Bluephase G4 - the latest curing light from Ivoclar Vivadent - comes in. The fourth generation of the Bluephase family does not only look stylish but it also offers a new and uniquely user-friendly feature: Polyvision technology. 

Vibration alerts users to application error 
Polyvision technology enables the Bluephase G4 to detect if the handpiece is moved during the exposure process and if the restoration can no longer be cured reliably. If this happens, the light emits a vibration alert to inform the operator of the error and, if necessary, automatically extends the exposure time by 10 per cent. If the handpiece moves too much – for example the light guide slips out of the oral cavity - the light automatically switches off so that the curing procedure can be repeated correctly. The advantages for the operator are: easy handling, discreet assistance, reliable curing results and satisfied patients. 

A curing light that communicates with the operator
With its automated assistance system, the Bluephase G4 represents a whole new generation of curing lights that can do both: cure reliably and communicate with their operators. The curing light offers a light output of 1200 mW/cm2, polywave LED technology in a broadband spectrum of 385 to 515 nm and a 10-mm wide light guide with a homogeneous beam profile. These features allow an exceptionally efficient application to achieve high-quality results in very short times. 

Bluephase® is a registered trademark of Ivoclar Vivadent AG. 


For more informations: Ivoclar Vivadent AG Bendererstrasse 2 9494 Schaan/Liechtenstein Tel.: +423 235 35 35 Fax: +423 235 33 60 E-Mail: info@ivoclarvivadent.com ; www.ivoclarvivadent.com
Media contact: 
André Büssers Public Relations Manager Ivoclar Vivadent AG Bendererstrasse 2 9494 Schaan/Liechtenstein Tel.: +423 235 36 98 Fax: +423 235 36 33.  E-mail: andre.buessers@ivoclarvivadent.com

Related articles

Join master dental technician Roberto Rossi, founder and president of Synergy Dental Ceramics, for an extended, in-depth walkthrough of Komet’s new ETNA Grinders and Polishers designed for full...


Give Kids A Smile events led to thousands of children in underserved communities receiving access to oral healthcare across New York this February during Children’s Dental Health Month. 


Zahn Dental, the U.S. dental laboratory business of Henry Schein, Inc. (Nasdaq: HSIC), has launched Zirlux® Independence ML. 


The next generation Trident X-View 3D CBCT product line is now available through Mid America Dental Sales, a master distributor of dental technology. These advanced imaging systems from Italy are...


Georgia School of Orthodontics (GSO) announced the appointment of Mohamed I. Masoud, BDS, DMSc, a Diplomate of the American Board of Orthodontics, as its new Director of Research. A distinguished...


Read more

Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Dentium Co., Ltd. (“Dentium” or the “Company”), has submitted formal shareholder proposals for inclusion in the...


Angelalign Technology Inc. (6699.HK) (“Angel”) said a ruling by the Unified Patent Court of Düsseldorf, Germany, that it preliminarily cease its use of certain software functions that...


A digital workflow for prosthetic implant rehabilitation can start either from intraoral scans or from the scan of the patient cast models. However, the possibility of scanning oral impressions is...


Texas A&M College of Dentistry recently entered into an agreement with Shear Kershman Laboratories and medical device company Innovative MedTech Inc. to study BioViscid, a pharmaceutical delivery...


Purposefully designed to support patients, providers and practice performance


 
 
 
 

 
 
 
 

Most popular

 
 

Events